July 14, 2024 This Week Top S&P 500 Gainers & Losers
Tesla Q2: The Bottom Is Likely In
Tesla: Time To Take Profits
Microsoft: The Q4 Results Should Surprise You
Tesla: Optimus And FSD Probably Won’t Save The Day
April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?
April 12, 2024 Improve Your Financial Status: A How-To Guide
April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade
March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5
Alnylam Pharmaceuticals (ALNY) Stock Forecast for 2024–2028. Sell or Buy?
Updated: July 27, 2024 (00:58)
Sector: HealthcareThe share price of Alnylam Pharmaceuticals, Inc. (ALNY) now
50/200 Day Moving Average: $193.44 / $171.8
This figure corresponds to the Average Price over the previous 50/200 days. For Alnylam Pharmaceuticals stocks, the 50-day moving average is the support level today.
For Alnylam Pharmaceuticals stocks, the 200-day moving average is the support level today.
Are you interested in Alnylam Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Alnylam Pharmaceuticals stock price in 2024, 2025, 2026, 2027, 2028. How much will one Alnylam Pharmaceuticals share be worth in 2024 - 2028?
When should I take profit in Alnylam Pharmaceuticals stock? When should I record a loss on Alnylam Pharmaceuticals stock? What are analysts' forecasts for Alnylam Pharmaceuticals stock? What is the future of Alnylam Pharmaceuticals stock? We forecast Alnylam Pharmaceuticals stock performance using neural networks based on historical data on Alnylam Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.
Alnylam Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2024, 2025, 2026, 2027 and 2028) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Alnylam Pharmaceuticals shares. This happens once a day.
Historical and forecast chart of Alnylam Pharmaceuticals stock
The chart below shows the historical price of Alnylam Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Alnylam Pharmaceuticals stock price can be found in the table below.
Long-term forecasts by years.
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, is engaged in the discovery, development and commercialization of RNA interference (RNAi) therapeutics. The company’s line of investigated RNAi therapies focuses on genetic drugs, cardiovascular diseases, liver infections, and central nervous system (CNS) / eye diseases.
Alnylam Pharmaceuticals daily forecast for a month
| Date | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jul 28 | 234.27 | 230.66 | 235.30 | 2.01 |
| Jul 29 | 233.70 | 231.37 | 237.16 | 2.51 |
| Jul 30 | 235.34 | 232.52 | 238.26 | 2.47 |
| Jul 31 | 231.76 | 229.26 | 232.78 | 1.54 |
| Aug 01 | 235.33 | 232.60 | 238.25 | 2.43 |
| Aug 02 | 234.16 | 230.41 | 236.03 | 2.44 |
| Aug 03 | 232.00 | 230.05 | 234.69 | 2.02 |
| Aug 04 | 233.30 | 230.27 | 235.03 | 2.07 |
| Aug 05 | 235.03 | 232.02 | 238.32 | 2.71 |
| Aug 06 | 235.17 | 233.71 | 236.81 | 1.33 |
| Aug 07 | 236.91 | 233.83 | 238.28 | 1.90 |
| Aug 08 | 237.24 | 233.82 | 240.70 | 2.94 |
| Aug 09 | 240.09 | 236.73 | 241.62 | 2.07 |
| Aug 10 | 244.41 | 241.52 | 247.20 | 2.35 |
| Aug 11 | 243.14 | 239.34 | 245.96 | 2.76 |
| Aug 12 | 243.53 | 240.31 | 244.79 | 1.86 |
| Aug 13 | 246.74 | 245.21 | 248.12 | 1.19 |
| Aug 14 | 246.35 | 243.83 | 248.42 | 1.88 |
| Aug 15 | 243.88 | 242.71 | 247.00 | 1.77 |
| Aug 16 | 240.62 | 238.93 | 244.18 | 2.20 |
| Aug 17 | 242.20 | 240.75 | 243.75 | 1.25 |
| Aug 18 | 243.75 | 242.39 | 247.12 | 1.95 |
| Aug 19 | 247.65 | 245.67 | 250.82 | 2.10 |
| Aug 20 | 247.75 | 245.47 | 249.64 | 1.70 |
| Aug 21 | 250.48 | 249.38 | 252.93 | 1.43 |
| Aug 22 | 253.38 | 249.94 | 255.36 | 2.17 |
| Aug 23 | 253.64 | 250.85 | 255.56 | 1.88 |
| Aug 24 | 252.72 | 250.55 | 254.24 | 1.47 |
| Aug 25 | 248.12 | 245.64 | 249.76 | 1.68 |
| Aug 26 | 245.74 | 243.53 | 249.03 | 2.26 |
Alnylam Pharmaceuticals Daily Price Targets
Alnylam Pharmaceuticals Stock Forecast 07-28-2024.
Forecast target price for 07-28-2024: $234.27.
Negative dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 1.971%.
Pessimistic target level: 230.66
Optimistic target level: 235.30
Alnylam Pharmaceuticals Stock Forecast 07-29-2024.
Forecast target price for 07-29-2024: $233.70.
Negative dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 2.444%.
Pessimistic target level: 231.37
Optimistic target level: 237.16
Alnylam Pharmaceuticals Stock Forecast 07-30-2024.
Forecast target price for 07-30-2024: $235.34.
Positive dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 2.410%.
Pessimistic target level: 232.52
Optimistic target level: 238.26
Alnylam Pharmaceuticals Stock Forecast 07-31-2024.
Forecast target price for 07-31-2024: $231.76.
Negative dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 1.513%.
Pessimistic target level: 229.26
Optimistic target level: 232.78
Alnylam Pharmaceuticals Stock Forecast 08-01-2024.
Forecast target price for 08-01-2024: $235.33.
Positive dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 2.371%.
Pessimistic target level: 232.60
Optimistic target level: 238.25
Alnylam Pharmaceuticals Stock Forecast 08-02-2024.
Forecast target price for 08-02-2024: $234.16.
Negative dynamics for Alnylam Pharmaceuticals shares will prevail with possible volatility of 2.381%.
Pessimistic target level: 230.41
Optimistic target level: 236.03
ALNY (ALNY) Monthly Stock Prediction for 2024
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Aug. | 250.96 | 229.43 | 264.77 | 13.35 |
| Sep. | 260.90 | 249.71 | 270.95 | 7.84 |
| Oct. | 267.22 | 256.34 | 277.21 | 7.53 |
| Nov. | 276.03 | 263.89 | 285.75 | 7.65 |
| Dec. | 245.67 | 232.43 | 260.80 | 10.88 |
Alnylam Pharmaceuticals forecast for this year
Alnylam Pharmaceuticals Stock Prediction for Aug 2024
An uptrend is forecast for this month with an optimal target price of $250.963. Pessimistic: $229.43. Optimistic: $264.77
Alnylam Pharmaceuticals Stock Prediction for Sep 2024
An uptrend is forecast for this month with an optimal target price of $260.902. Pessimistic: $249.71. Optimistic: $270.95
Alnylam Pharmaceuticals Stock Prediction for Oct 2024
An uptrend is forecast for this month with an optimal target price of $267.215. Pessimistic: $256.34. Optimistic: $277.21
Alnylam Pharmaceuticals Stock Prediction for Nov 2024
An uptrend is forecast for this month with an optimal target price of $276.033. Pessimistic: $263.89. Optimistic: $285.75
Alnylam Pharmaceuticals Stock Prediction for Dec 2024
An downtrend is forecast for this month with an optimal target price of $245.67. Pessimistic: $232.43. Optimistic: $260.80
Alnylam Pharmaceuticals (ALNY) Monthly Stock Prediction for 2025
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 234.59 | 223.24 | 240.78 | 7.29 |
| Feb | 222.98 | 217.34 | 228.37 | 4.83 |
| Mar | 233.03 | 217.65 | 248.93 | 12.56 |
| Apr | 236.37 | 222.59 | 249.11 | 10.65 |
| May | 234.03 | 220.13 | 254.62 | 13.55 |
| Jun | 240.21 | 228.32 | 255.53 | 10.65 |
| Jul | 243.38 | 234.81 | 253.55 | 7.39 |
| Aug | 253.01 | 236.31 | 274.17 | 13.81 |
| Sep | 262.75 | 252.93 | 275.18 | 8.09 |
| Oct | 277.50 | 264.06 | 297.64 | 11.28 |
| Nov | 302.22 | 279.95 | 322.50 | 13.19 |
| Dec | 332.14 | 308.39 | 349.68 | 11.81 |
Alnylam Pharmaceuticals (ALNY) Monthly Stock Prediction for 2026
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 348.58 | 332.09 | 377.34 | 11.99 |
| Feb | 337.84 | 328.93 | 355.31 | 7.43 |
| Mar | 311.83 | 297.77 | 320.75 | 7.17 |
| Apr | 299.48 | 279.72 | 321.55 | 13.01 |
| May | 289.60 | 264.75 | 306.48 | 13.62 |
| Jun | 285.78 | 274.77 | 304.95 | 9.90 |
| Jul | 283.89 | 262.34 | 297.32 | 11.76 |
| Aug | 272.34 | 251.07 | 291.21 | 13.78 |
| Sep | 285.82 | 272.30 | 307.82 | 11.54 |
| Oct | 281.10 | 272.75 | 303.98 | 10.27 |
| Nov | 259.46 | 245.47 | 269.16 | 8.80 |
| Dec | 254.03 | 238.38 | 275.55 | 13.49 |
Alnylam Pharmaceuticals (ALNY) Monthly Stock Prediction for 2027
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 251.80 | 236.84 | 259.55 | 8.75 |
| Feb | 249.58 | 238.05 | 259.74 | 8.35 |
| Mar | 274.29 | 250.15 | 293.30 | 14.71 |
| Apr | 293.90 | 277.74 | 315.89 | 12.08 |
| May | 312.01 | 287.30 | 336.03 | 14.50 |
| Jun | 297.25 | 290.06 | 321.44 | 9.76 |
| Jul | 316.54 | 308.88 | 344.40 | 10.31 |
| Aug | 346.14 | 328.62 | 375.07 | 12.38 |
| Sep | 378.12 | 367.72 | 403.91 | 8.96 |
| Oct | 358.15 | 345.15 | 368.40 | 6.31 |
| Nov | 374.70 | 363.99 | 392.42 | 7.25 |
| Dec | 370.58 | 348.57 | 383.22 | 9.04 |
Alnylam Pharmaceuticals (ALNY) Monthly Stock Prediction for 2028
| Month | Target | Pes. | Opt. | Vol., % |
|---|---|---|---|---|
| Jan | 366.50 | 335.46 | 384.24 | 12.70 |
| Feb | 364.49 | 355.67 | 382.53 | 7.02 |
| Mar | 374.91 | 364.19 | 395.53 | 7.92 |
| Apr | 413.68 | 394.57 | 433.24 | 8.93 |
| May | 442.35 | 423.86 | 455.48 | 6.94 |
| Jun | 436.02 | 424.03 | 474.39 | 10.62 |
| Jul | 435.06 | 413.53 | 469.52 | 11.93 |
| Aug | 413.53 | 402.61 | 440.82 | 8.67 |
| Sep | 414.89 | 387.05 | 447.75 | 13.56 |
| Oct | 392.07 | 376.11 | 401.56 | 6.34 |
| Nov | 376.98 | 364.54 | 406.83 | 10.40 |
| Dec | 375.32 | 344.77 | 384.40 | 10.31 |
Alnylam Pharmaceuticals information and performance
675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, US
Market capitalization of the Alnylam Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ALNY shares in the company outstanding by the market price of one share.
EBITDA of Alnylam Pharmaceuticals is earnings before interest, income tax and depreciation of assets.
P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit
Price/earnings to growth
Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
EPS shows how much of the net profit is accounted for by the common share.
Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.
Forward P/E uses projections of future earnings instead of final numbers.
Enterprise Value (EV) /Revenue
The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).
Number of issued ordinary shares
Number of freely tradable shares
Shares Short Prior Month - the number of shares in short positions in the last month.
